- Previous Close
56.90 - Open
56.90 - Bid 57.80 x --
- Ask 58.00 x --
- Day's Range
56.70 - 57.90 - 52 Week Range
48.58 - 61.70 - Volume
54,232 - Avg. Volume
45,327 - Market Cap (intraday)
3.416B - Beta (5Y Monthly) -0.22
- PE Ratio (TTM)
38.09 - EPS (TTM)
1.52 - Earnings Date --
- Forward Dividend & Yield 0.57 (1.00%)
- Ex-Dividend Date Aug 20, 2024
- 1y Target Est
--
G&E Herbal Biotechnology Co., Ltd. engages in development and commercialization of novel botanical extraction technology and products. It offers Hepanamin capsules; botoniocal healthcare product, such as SR100, Goji-Ex, arthrenhergy plus, astragali radix, and prosta capsules; botanical anti-aging cosmetic, which includes rejuvenate haute essential set, classic selection set, facial cleansing essence, botonic extract toner, moisturizing cream, and serum, and essential oil; smile cream and topical gel; and adult products, including lubricants. G&E Herbal Biotechnology Co., Ltd. was founded in 2002 and is based in Tainan City, Taiwan.
www.geherbs.com.twRecent News: 4911.TWO
View MorePerformance Overview: 4911.TWO
Trailing total returns as of 2/7/2025, which may include dividends or other distributions. Benchmark is .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: 4911.TWO
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: 4911.TWO
View MoreValuation Measures
Market Cap
3.36B
Enterprise Value
3.07B
Trailing P/E
37.52
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
14.87
Price/Book (mrq)
4.18
Enterprise Value/Revenue
13.60
Enterprise Value/EBITDA
25.23
Financial Highlights
Profitability and Income Statement
Profit Margin
39.70%
Return on Assets (ttm)
7.09%
Return on Equity (ttm)
11.20%
Revenue (ttm)
211.15M
Net Income Avi to Common (ttm)
83.82M
Diluted EPS (ttm)
1.52
Balance Sheet and Cash Flow
Total Cash (mrq)
324.13M
Total Debt/Equity (mrq)
0.29%
Levered Free Cash Flow (ttm)
113.95M